Free Trial

Evoke (LON:EVOK) Stock Price Down 10% - Should You Sell?

Evoke logo with Consumer Cyclical background
Remove Ads

Evoke plc (LON:EVOK - Get Free Report)'s stock price traded down 10% during trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares changed hands during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).

Analyst Upgrades and Downgrades

EVOK has been the subject of a number of recent analyst reports. Berenberg Bank lowered their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group restated a "buy" rating and issued a GBX 140 ($1.81) price target on shares of Evoke in a research note on Monday, December 16th.

Check Out Our Latest Stock Analysis on Evoke

Evoke Stock Down 5.3 %

The stock has a 50 day moving average of GBX 68.36 and a 200 day moving average of GBX 63.39. The firm has a market capitalization of £211.75 million, a price-to-earnings ratio of -1.19 and a beta of 0.84.

Evoke (LON:EVOK - Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Analysts predict that Evoke plc will post 12.7648305 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Andrea Gisle Joosen acquired 14,572 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was purchased at an average cost of GBX 70 ($0.90) per share, for a total transaction of £10,200.40 ($13,178.81). 27.00% of the stock is owned by company insiders.

About Evoke

(Get Free Report)

Recommended Stories

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads